S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
WSC Sports Was Built on a Love for Sports. It Changed The Entire Game.
Ride These Railroad Stocks for Growth and Income
Is This The End of Capitalism? (Ad)
EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
Is This The End of Capitalism? (Ad)
Microsoft’s Comeback Is Now Underway
Can Amazon Recover Amid Tech Stock Sell-off?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
WSC Sports Was Built on a Love for Sports. It Changed The Entire Game.
Ride These Railroad Stocks for Growth and Income
Is This The End of Capitalism? (Ad)
EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
Is This The End of Capitalism? (Ad)
Microsoft’s Comeback Is Now Underway
Can Amazon Recover Amid Tech Stock Sell-off?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
WSC Sports Was Built on a Love for Sports. It Changed The Entire Game.
Ride These Railroad Stocks for Growth and Income
Is This The End of Capitalism? (Ad)
EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
Is This The End of Capitalism? (Ad)
Microsoft’s Comeback Is Now Underway
Can Amazon Recover Amid Tech Stock Sell-off?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
WSC Sports Was Built on a Love for Sports. It Changed The Entire Game.
Ride These Railroad Stocks for Growth and Income
Is This The End of Capitalism? (Ad)
EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
Is This The End of Capitalism? (Ad)
Microsoft’s Comeback Is Now Underway
Can Amazon Recover Amid Tech Stock Sell-off?

CVS Health is Growing into an Integrated Healthcare Organization

Key Points

  • CVS Health is a provider and payor of health care services offering Minute Clinic and Medicare Advantage Plans.
  • The Company saw growth in all its segments except for Retail due to the decrease in COVID tests and vaccinations.
  • CVS Health shares are trading near their 52-week lows at 10X forward earnings with a 2.78% annual dividend yield
  • 5 stocks we like better than CVS Health

CVS Health is Growing into an Integrated Healthcare Organization

Pharmacy, insurance, and healthcare services provider CVS Health Corporation (NYSE: CVS) shares are trading near 52-week lows despite the recent rally in the benchmark indices. The Company has evolved from a drug store chain into an integrated healthcare company offering healthcare provider and payor services.

It competes with Walgreens Boots Alliance Inc. (NYSE: WBA) and Rite-Aid Co. (NYSE: RAD) in the pharmacy benefits management segment. Incidentally, CVS Health and Walgreens agreed to a $10.7 billion settlement over their roles in the opioid crisis without admitting fault. As a result, CVS will be paying out $5 billion over ten years.

The Company is firing on all cylinders. It saw revenue and adjusted operating income growth in its Health Care Benefits, Pharmacy, and Insurance segments, with top-line growth in its retail drug store business but a (-18.9%) decline in adjusted operating income due to normalization from the decrease in COVID tests and vaccinations

Primary Care Services

CVS Health offers primary care services through its Minute Clinics and Signify Health network of over 10,000 physicians while providing pharmacy benefits management services and filling prescriptions for its customers. CVS is one of the world's largest pharmacy drug stores with over 9.9K retail pharmacies with over 1,100 walk-in clinics in the U.S.


By being both a provider and payor. The Company has transformed into an integrated healthcare organization looking to grow its primary care footprint.   

Health Insurer

The $69 billion acquisition of Aetna Health insurance in 2018 made CVS Health a payor of healthcare services as an insurer. Its Aetna Health insurance division added 590,000 members in its latest quarter generating 10% top-line growth. It provides health insurance products for employers, individuals, college students, healthcare providers, labor groups, government-sponsored plans, and Medicare Advantage.

Medicare Advantage is an alternative to the traditional Medicare part C insurance for seniors paid out of Social Security benefits offered by the U.S. government.

Medicare Advantage

Medicare Advantage for seniors offers HMO and PPO plans that usually include all services minus a co-pay versus the 80/20 insurer and patient responsibility mix through traditional Medicare. They also have additional services that traditional Medicare doesn't, like vision, dental, hearing, and wellness programs.

Medicare Advantage plans also cover prescription drugs with lower out-of-pocket costs. Medicare Advantage has been a growth driver for competitors like Humana (NYSE: HUM), UnitedHealth Group  (NYSE: UNH), Cigna Corporation (NYSE: CI), and Anthem Inc. 

Consistent Earnings Beat

On Nov. 2, 2022, CVS Health reported its fiscal Q3 2022 earnings report for the quarter ending September 2022. The Company reported a non-GAAP earnings-per-share (EPS) profit of $2.09, excluding non-recurring items, versus consensus analyst estimates for a profit of $1.99, a $0.10 beat.

Revenues grew 10% year-over-year (YoY) to $81.16 billion, beating analyst estimates of $76.78 billion. Its Health Care Benefits segment grew 9.9%, with a 39.6% increase in adjusted operating income. The Pharmacy segment saw 10.7% YoY revenue growth as adjusted operating income rose 5.9% while total pharmacy claims processed rose only 3.6%.

Its Retail segment sales rose 6.9% but adjusted operating income fell (-18.9%) due to lower COVID-19 tests and vaccinations.

CVS Health CEO Karen Lynch commented, "We delivered another outstanding quarter and have raised full-year guidance as a result. We continue to execute our strategy with a focus on expanding capabilities in health care delivery, and the announced acquisition of Signify Health will further strengthen our engagement with consumers."

Raising Guidance

CVS Health raised its fiscal full-year 2022 EPS guidance from $8.55 to $8.65 versus $8.55 consensus analyst estimates. Its original range was for EPS to come in between $8.40 to $8.60. In addition, the Company raised cash flow from operations guidance ranges from $13.5 billion to $14.5 billion, up from $12.5 billion to $13.5 billion.

CVS Health is Growing into an Integrated Healthcare Organization

Weekly Rectangle Breakdown Set-Up

CVS's weekly candlestick chart illustrates the rectangle trading range it has been in since April 2022. The upper range resistance sits at $107.60, while the lower range support sits at $86.28. As a result, shares have been bucking the rising market as it heads towards 52-week lows.

The weekly stochastic is coming down as shares triggered the weekly market structure high (MSH) sell signal on the $99.98 breakdown. The weekly MSL buy trigger was flushed as shares fell below the $93.16 trigger heading towards the $86.28 lower rectangle range trendline.

The weekly 20-period exponential moving average (EMA) resistance continues to fall at $95.07, followed by the weekly 50-period M.A. resistance falling at $98.11. Pullback supports sit at $86.28 swing low and lower rectangle trendline, $83.57, $81.78, $79.33, and $77.13.

      

Should you invest $1,000 in CVS Health right now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
13 Stocks Institutional Investors Won't Stop Buying Cover

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
CVS Health (CVS)
3.0952 of 5 stars
$87.78+0.1%2.76%37.35Moderate Buy$119.13
Walgreens Boots Alliance (WBA)
2.6015 of 5 stars
$37.17+1.8%5.17%-10.81Hold$43.46
Rite Aid (RAD)
0.8917 of 5 stars
$3.59+4.1%N/A-0.22Reduce$3.75
UnitedHealth Group (UNH)
3.3933 of 5 stars
$486.05-1.3%1.36%22.94Moderate Buy$599.39
Humana (HUM)
3.3918 of 5 stars
$481.69-3.5%0.65%21.85Moderate Buy$602.50
Cigna (CI)
2.9238 of 5 stars
$308.30-1.6%1.45%14.72Moderate Buy$329.45
Compare These Stocks  Add These Stocks to My Watchlist 

Jea Yu

About Jea Yu

Contributing Author: Trading Strategies

With over 20 years of active participation and analysis of the US equities, options and futures markets, Mr. Yu brings fresh insights into the workings of the financial markets. He has published four books by esteemed publishers McGraw-Hill, John Wiley & Sons, Marketplace Books and Bloomberg Press. His brainchild, the Underground Trader, was voted Forbes Best of the Web for four consecutive years under the active trader category. He has been a featured speaker all over the country at various expos and seminars who enjoys a standing-room-only reception in the largest convention halls from New York to Las Vegas. He has been quoted and featured in USA Today, Wall Street Journal, Traders Magazine and the Financial Times and various trade publications like Stocks & Commodities, Active Trader and Online Investor. Mr. Yu has a B.A. in Liberal Arts and minor in Business Administration from the University of Maryland.
Contact Jea Yu via email at JeaYu21@gmail.com.

Featured Articles and Offers

Search Headlines: